Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2026)

Evolent Health's Amortization of Deferred Charges history runs 10 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 155.55% year-over-year to $2.9 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 150.5% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 120.02% from the prior year.
• Amortization of Deferred Charges fell to $2.9 million in Q1 2026 per EVH's latest filing, from $3.0 million in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $3.0 million in Q4 2025 and bottomed at $46000.0 in Q2 2023.
• The 5-year median for Amortization of Deferred Charges is $539000.0 (2022), against an average of $783117.6.
• Across the five-year window, Amortization of Deferred Charges slumped 95.0% in 2022 and jumped 943.48% in 2024, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $540000.0 in 2022, then jumped by 66.67% to $900000.0 in 2023, then retreated by 0.33% to $897000.0 in 2024, then soared by 239.13% to $3.0 million in 2025, then declined by 3.06% to $2.9 million in 2026.
• Per Business Quant, the three latest EVH Amortization of Deferred Charges figures stand at $2.9 million (Q1 2026), $3.0 million (Q4 2025), and $106000.0 (Q3 2025).